Investec Bank Plc has filed a Form 8.5 disclosure under Rule 8.5 of the Takeover Code regarding dealings in Advanced Medical Solutions Group Plc shares.
The disclosure was submitted in Investec’s capacity as an exempt principal trader with recognised intermediary status, dealing in a client-serving capacity.
Investec Bank Plc serves as Advisor and Joint Broker to Advanced Medical Solutions Group Plc, establishing its connected status to the offer party named in the filing.
The dealings were undertaken on 29th September 2026, with the formal disclosure date recorded as 30th September 2026.
During the dealing period, Investec purchased a total of 27,880 ordinary shares in Advanced Medical Solutions Group Plc on that date.
The purchases were executed at prices ranging from a low of 282.02 pence per unit to a high of 282.25 pence per unit.
On the same date, Investec also recorded sales of 58,346 ordinary shares, at prices ranging between 282 and 282.25 pence per unit.
The volume of shares sold was notably higher than those purchased, reflecting the firm’s activity in its client-serving capacity as a market intermediary.
No cash-settled derivative transactions, stock-settled derivative transactions, or options were reported as part of this disclosure filing.
Investec confirmed there are no indemnity arrangements, option agreements, or any formal or informal understandings relating to relevant securities that may constitute an inducement to deal or refrain from dealing.
The firm also confirmed no agreements or understandings exist relating to voting rights under any option or derivative referenced to Advanced Medical Solutions Group Plc securities.
The contact named in the disclosure is Abhishek Gawde, reachable by telephone for any regulatory follow-up relating to the filing.
Public disclosures of this nature under Rule 8 of the Takeover Code are required to be made to a Regulatory Information Service in accordance with applicable regulations.
